BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 8590306)

  • 1. Tumor necrosis factor alpha and interleukin-1 alpha stimulate late shedding of p75 TNF receptors but not p55 TNF receptors from human monocytes.
    Joyce DA; Steer JH
    J Interferon Cytokine Res; 1995 Nov; 15(11):947-54. PubMed ID: 8590306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-4, IL-10 and IFN-gamma have distinct, but interacting, effects on differentiation-induced changes in TNF-alpha and TNF receptor release by cultured human monocytes.
    Joyce DA; Steer JH
    Cytokine; 1996 Jan; 8(1):49-57. PubMed ID: 8742066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone suppresses release of soluble TNF receptors by human monocytes concurrently with TNF-alpha suppression.
    Joyce DA; Kloda A; Steer JH
    Immunol Cell Biol; 1997 Aug; 75(4):345-50. PubMed ID: 9315475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein.
    Leeuwenberg JF; Dentener MA; Buurman WA
    J Immunol; 1994 May; 152(10):5070-6. PubMed ID: 7513728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.
    Galve-de Rochemonteix B; Nicod LP; Dayer JM
    Am J Respir Cell Mol Biol; 1996 Mar; 14(3):279-87. PubMed ID: 8845179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H
    Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes.
    Joyce DA; Gibbons DP; Green P; Steer JH; Feldmann M; Brennan FM
    Eur J Immunol; 1994 Nov; 24(11):2699-705. PubMed ID: 7957562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor.
    Alsalameh S; Mattka B; Al-Ward R; Lorenz HM; Manger B; Pfizenmaier K; Grell M; Kalden JR
    J Rheumatol; 1999 Mar; 26(3):645-53. PubMed ID: 10090177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p55 and p75 tumor necrosis factor receptors are expressed and mediate common functions in synovial fibroblasts and other fibroblasts.
    Butler DM; Feldmann M; Di Padova F; Brennan FM
    Eur Cytokine Netw; 1994; 5(5):441-8. PubMed ID: 7880974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients.
    Jablońska E; Kiluk M; Piotrowski L; Grabowska Z; Markiewicz W; Jablonski J
    Eur Cytokine Netw; 1998 Jun; 9(2):155-9. PubMed ID: 9681391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble tumor necrosis factor (TNF) receptors p55 and p75 and interleukin-10 downregulate TNF-alpha activity during the lung response to silica particles in NMRI mice.
    Huaux F; Arras M; Vink A; Renauld JC; Lison D
    Am J Respir Cell Mol Biol; 1999 Jul; 21(1):137-45. PubMed ID: 10385602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow release of soluble TNF receptors by monocytes in vitro.
    Leeuwenberg JF; Jeunhomme TM; Buurman WA
    J Immunol; 1994 Apr; 152(8):4036-43. PubMed ID: 8144970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
    Núñez-González JR; Sanabria-Vera CJ; Romero-Adrián T
    Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of cytokine receptors sTNF-R55, sTNF-R75, and sIL-2R in psoriatic arthritis synovial fluid.
    Partsch G; Wagner E; Leeb BF; Dunky A; Steiner G; Smolen JS
    J Rheumatol; 1998 Jan; 25(1):105-10. PubMed ID: 9458212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial cell contact potentiates release of soluble tumor necrosis factor (TNF) receptors from the monocyte-like cell line THP-1.
    Björnberg F; Lantz M
    J Interferon Cytokine Res; 1998 Mar; 18(3):167-74. PubMed ID: 9555978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of soluble tumor necrosis factor receptor (sTNF-R75) release by HIV adsorption on cultured human monocytes.
    Rimaniol AC; Boussin F; Herbelin A; De Groote D; Dormont D; Bach JF; Descamps-Latscha B; Zavala F
    Eur J Immunol; 1994 Sep; 24(9):2055-60. PubMed ID: 8088326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells.
    Gallea-Robache S; Morand V; Millet S; Bruneau JM; Bhatnagar N; Chouaib S; Roman-Roman S
    Cytokine; 1997 May; 9(5):340-6. PubMed ID: 9195133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of TNF-α, sTNF-R55 and sTNF-R75 in inflammation of acute exacerbations of chronic obstructive pulmonary disease.
    Zeng M; Wen Y; Liu LY; Wang H; Guan KP; Huang X
    Respiration; 2009; 78(4):399-403. PubMed ID: 19339767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures.
    Williams LM; Gibbons DL; Gearing A; Maini RN; Feldmann M; Brennan FM
    J Clin Invest; 1996 Jun; 97(12):2833-41. PubMed ID: 8675695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoarthritic synovial fibroblasts possess an increased level of tumor necrosis factor-receptor 55 (TNF-R55) that mediates biological activation by TNF-alpha.
    Alaaeddine N; DiBattista JA; Pelletier JP; Cloutier JM; Kiansa K; Dupuis M; Martel-Pelletier J
    J Rheumatol; 1997 Oct; 24(10):1985-94. PubMed ID: 9330943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.